ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$282,000
+2.2%
48,644
-24.6%
0.00%0.0%
Q2 2018$276,000
-62.1%
64,544
-48.0%
0.00%
-50.0%
Q1 2018$728,000
+11.1%
124,064
-12.4%
0.00%0.0%
Q4 2017$655,000
+12.5%
141,700
+33.7%
0.00%0.0%
Q3 2017$582,000
+43.0%
106,000
+50.0%
0.00%
+100.0%
Q2 2017$407,00070,6440.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$6,282,0002.96%
COURAGE CAPITAL MANAGEMENT LLC 100,000$527,0000.33%
Crawford Lake Capital Management, LLC 69,100$364,0000.26%
Hall Kathryn A. 31,355$166,0000.20%
ELLINGTON MANAGEMENT GROUP LLC 29,300$154,0000.02%
REILLY FINANCIAL ADVISORS, LLC 22,011$116,0000.02%
Virtu KCG Holdings LLC 150,357$792,0000.02%
THOMPSON DAVIS & CO., INC. 2,000$11,0000.02%
Jasper Ridge Partners, L.P. 47,481$250,0000.02%
AXA S.A. 479,686$2,528,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders